XML 40 R116.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidating Financial Statements of Aramark and Subsidiaries - Condensed Consolidating Statements of Income and Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 27, 2019
Jun. 28, 2019
Mar. 29, 2019
Dec. 28, 2018
Sep. 28, 2018
Jun. 29, 2018
Mar. 30, 2018
Dec. 29, 2017
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Condensed Financial Statements, Captions [Line Items]                      
Revenue $ 3,951,244 $ 4,010,761 $ 3,999,987 $ 4,265,349 $ 3,913,598 $ 3,971,606 $ 3,939,311 $ 3,965,118 $ 16,227,341 $ 15,789,633 $ 14,604,412
Costs and Expenses:                      
Cost of services provided                 14,532,662 13,997,911 12,995,403
Depreciation and amortization                 592,573 596,182 508,212
Selling and general corporate expenses                 367,256 377,129 299,170
Gain on sale of Healthcare Technologies                 (156,309) 0 0
Interest and other financing costs, net                 334,987 346,535 280,985
Expense allocations                 0 0 0
Costs and Expenses                 15,671,169 15,317,757 14,083,770
Income (Loss) before Income Taxes                 556,172 471,876 520,642
Provision (Benefit) for Income Taxes                 107,706 (96,564) 146,455
Equity in Net Income of Subsidiaries                 0 0 0
Net income (loss)                 448,466 568,440 374,187
Less: Net income (loss) attributable to noncontrolling interest                 (83) 555 264
Net income (loss) attributable to Aramark stockholders $ 85,557 $ 82,955 $ 29,353 $ 250,682 $ 175,455 $ 72,577 $ 27,569 $ 292,284 448,549 567,885 373,923
Other comprehensive income (loss), net of tax                 (125,742) 32,537 57,023
Comprehensive income attributable to Aramark stockholders                 322,807 600,422 430,946
Eliminations                      
Condensed Financial Statements, Captions [Line Items]                      
Revenue                 0 0 0
Costs and Expenses:                      
Cost of services provided                 0 0 0
Depreciation and amortization                 0 0 0
Selling and general corporate expenses                 0 0 0
Gain on sale of Healthcare Technologies                 0    
Interest and other financing costs, net                 0 0 0
Expense allocations                 0 0 0
Costs and Expenses                 0 0 0
Income (Loss) before Income Taxes                 0 0 0
Provision (Benefit) for Income Taxes                 0 0 0
Equity in Net Income of Subsidiaries                 (448,549) (567,885) (373,923)
Net income (loss)                 (448,549) (567,885) (373,923)
Less: Net income (loss) attributable to noncontrolling interest                 0 0 0
Net income (loss) attributable to Aramark stockholders                 (448,549) (567,885) (373,923)
Other comprehensive income (loss), net of tax                 193,340 (10,088) (116,302)
Comprehensive income attributable to Aramark stockholders                 (255,209) (577,973) (490,225)
Aramark | Reportable Legal Entities                      
Condensed Financial Statements, Captions [Line Items]                      
Revenue                 0 0 0
Costs and Expenses:                      
Cost of services provided                 0 0 0
Depreciation and amortization                 0 0 0
Selling and general corporate expenses                 0 0 0
Gain on sale of Healthcare Technologies                 0    
Interest and other financing costs, net                 0 0 0
Expense allocations                 0 0 0
Costs and Expenses                 0 0 0
Income (Loss) before Income Taxes                 0 0 0
Provision (Benefit) for Income Taxes                 0 0 0
Equity in Net Income of Subsidiaries                 448,549 567,885 373,923
Net income (loss)                 448,549 567,885 373,923
Less: Net income (loss) attributable to noncontrolling interest                 0 0 0
Net income (loss) attributable to Aramark stockholders                 448,549 567,885 373,923
Other comprehensive income (loss), net of tax                 (125,742) 32,537 57,023
Comprehensive income attributable to Aramark stockholders                 322,807 600,422 430,946
Aramark Services, Inc. (Issuer) | Reportable Legal Entities                      
Condensed Financial Statements, Captions [Line Items]                      
Revenue                 1,062,655 1,027,573 1,041,490
Costs and Expenses:                      
Cost of services provided                 981,661 848,739 941,031
Depreciation and amortization                 16,377 19,466 17,502
Selling and general corporate expenses                 162,963 195,093 140,305
Gain on sale of Healthcare Technologies                 0    
Interest and other financing costs, net                 316,120 329,027 273,405
Expense allocations                 (315,432) (374,970) (348,042)
Costs and Expenses                 1,161,689 1,017,355 1,024,201
Income (Loss) before Income Taxes                 (99,034) 10,218 17,289
Provision (Benefit) for Income Taxes                 (38,388) (3,521) 5,139
Equity in Net Income of Subsidiaries                 0 0 0
Net income (loss)                 (60,646) 13,739 12,150
Less: Net income (loss) attributable to noncontrolling interest                 0 0 0
Net income (loss) attributable to Aramark stockholders                 (60,646) 13,739 12,150
Other comprehensive income (loss), net of tax                 (71,282) 43,686 35,667
Comprehensive income attributable to Aramark stockholders                 (131,928) 57,425 47,817
Guarantors | Reportable Legal Entities                      
Condensed Financial Statements, Captions [Line Items]                      
Revenue                 10,653,013 10,432,088 9,708,157
Costs and Expenses:                      
Cost of services provided                 9,362,232 9,132,991 8,507,705
Depreciation and amortization                 473,833 483,106 416,979
Selling and general corporate expenses                 176,714 158,064 138,304
Gain on sale of Healthcare Technologies                 (156,309)    
Interest and other financing costs, net                 3,531 266 (3,196)
Expense allocations                 274,501 353,628 318,199
Costs and Expenses                 10,134,502 10,128,055 9,377,991
Income (Loss) before Income Taxes                 518,511 304,033 330,166
Provision (Benefit) for Income Taxes                 109,144 (143,452) 98,144
Equity in Net Income of Subsidiaries                 0 0 0
Net income (loss)                 409,367 447,485 232,022
Less: Net income (loss) attributable to noncontrolling interest                 (83) 555 264
Net income (loss) attributable to Aramark stockholders                 409,450 446,930 231,758
Other comprehensive income (loss), net of tax                 (553) 3,178 431
Comprehensive income attributable to Aramark stockholders                 408,897 450,108 232,189
Non Guarantors | Reportable Legal Entities                      
Condensed Financial Statements, Captions [Line Items]                      
Revenue                 4,511,673 4,329,972 3,854,765
Costs and Expenses:                      
Cost of services provided                 4,188,769 4,016,181 3,546,667
Depreciation and amortization                 102,363 93,610 73,731
Selling and general corporate expenses                 27,579 23,972 20,561
Gain on sale of Healthcare Technologies                 0    
Interest and other financing costs, net                 15,336 17,242 10,776
Expense allocations                 40,931 21,342 29,843
Costs and Expenses                 4,374,978 4,172,347 3,681,578
Income (Loss) before Income Taxes                 136,695 157,625 173,187
Provision (Benefit) for Income Taxes                 36,950 50,409 43,172
Equity in Net Income of Subsidiaries                 0 0 0
Net income (loss)                 99,745 107,216 130,015
Less: Net income (loss) attributable to noncontrolling interest                 0 0 0
Net income (loss) attributable to Aramark stockholders                 99,745 107,216 130,015
Other comprehensive income (loss), net of tax                 (121,505) (36,776) 80,204
Comprehensive income attributable to Aramark stockholders                 $ (21,760) $ 70,440 $ 210,219